HGF and cancer: HGF Mab therapies were investigated for various cancers and included Rilotumumab (AMG102) from Amgen [95,104], Ficlatuzumab from AVEO pharmaceuticals and HuL2G7 from Millennium pharmaceuticals (www.vai.org/metclinicaltrials).